Crizanlizumab Antibody
Crizanlizumab is a humanized anti-P-selectin monoclonal antibody used to reduce the frequency of vaso-occlusive crises in sickle cell disease. It is applied in hematology research to study cell adhesion mechanisms, with utility in both in vitro binding assays and in vivo models of sickle cell pathophysiology.
Product Specifications
Product Name Alternative
P-selectin, ADAKVEO, SEG-101
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
9.84 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040948-500 1x 500 µL
Cytokeratin 5/8 (C-50), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740287-100 1x 100 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (66.4.C2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details